NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States

Search Results

7261. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: final policy recommendations

7263. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

7266. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

7267. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

7268. Tezepelumab for severe asthma: final report

7269. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

7270. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report